Quality control in peptide manufacturing is a comprehensive process that spans from raw material testing to final product release. The global CDMO Service for Peptide APIs market is projected to grow to US$ 13,186 million by 2032[reference:163], driving demand for robust quality control systems.
Raw material testing is the first step in quality control. Starting materials including protected amino acids, resins, and reagents must be tested to ensure they meet specifications. This testing includes identity, purity, and potency, with results documented and reviewed before materials are released for use.
In-process controls monitor the synthesis process to ensure it is proceeding as expected. These controls include monitoring of coupling efficiency (by Kaiser test or other methods), monitoring of deprotection efficiency, and monitoring of impurity profiles. In-process controls enable early detection of problems and prevent the production of out-of-specification material.
Final product testing is the most comprehensive phase of quality control. Testing includes HPLC for purity, mass spectrometry for identity, amino acid analysis for sequence verification, and other tests as appropriate. The product must meet all specifications before release. Stability testing is also conducted to establish shelf life.
Documentation is a critical component of quality control. All testing results must be documented and reviewed. Deviations must be investigated and documented. The complete quality record provides traceability and supports regulatory submissions.
At PeptideHub, our QC procedures follow strict protocols, ensuring each batch meets or exceeds your requirements before shipment. Our comprehensive quality system provides the documentation and traceability needed for research and clinical applications.